Shawn Olsson MBA

Shawn Olsson is seasoned pharma leader in the injectable and prefilled syringe industry. Shawn is responsible for a $0.5B US prefilled syringe business which includes 6 on market prefilled syringes and 30 distinct molecules. Prior to his commercial responsibility for Pfizer Injectables US Prefilled Syringe and Opioid portfolio, Shawn was the Director of On Market Strategy for Pfizer’s Global Injectable business and was the Director of On Market Strategy for Hospira’s $3B Global Generic Business Units.